Marshfield Based Preventiongenetics Earns Accreditation for Global Testing
PreventionGenetics, located in Marshfield, WI has achieved ISO 15189:2012 certification through A2LA. PreventionGenetics is a genetic testing laboratory.
Marshfield, WI, August 06, 2016 --(PR.com)-- PreventionGenetics, LLC, in Marshfield, Wisconsin achieved ISO 15189:2012 accreditation through the American Association for Laboratory Accreditation (A2LA). A2LA is a non-profit and independent, internationally-recognized accreditation body located in the United States.
PreventionGenetics is one of a few US based clinical genetic testing laboratories which have acquired the international quality assurance standard, making the company a provider of choice for international companies seeking NextGen panels, single gene tests, and deletion/duplication testing via high density gene-centric aCGH.
Formed in 2004, by Dr. James Weber, contributor to the Human Genome Project, PreventionGenetics is one of the most comprehensive genetic testing companies in the world. A large global contender, PreventionGenetics currently accepts samples routinely from over 70 countries, with comprehensive coverage for nearly 2,000 genes, in addition to whole exome sequencing (PGXome).
“ISO 15189:2012 provides the basis for which many health care systems and practitioners from all over the world use to select their preferred labs,” said Dr. James Weber, CEO and Founder. “We have built the foundation of this company on quality standards, supported by our large specialized PhD group. Certification confirms our lab standards for quality run as deep as our personal commitment to patient care through diagnostic expertise.”
ISO 15189:2012 defines specific quality and competency requirements particular to clinical laboratories. Certification confirms conditions within the laboratory setting are reproducible, leading to accurate results. The standard promotes global adoption of clinical practices for protection of the health and safety of patients and healthcare providers. ISO 15189:2012 also assesses the efficient exchange of information and protection of data for improved quality of care.
About Prevention Genetics
PreventionGenetics, LLC is a CAP and CLIA-accredited and ISO 15189:2012 certified lab which offers clinical molecular diagnostic testing for near 2,000 clinically-relevant genes. We offer a rapidly growing set of NextGen panels, single gene tests, and deletion/duplication testing. PreventionGenetics also offers Whole Exome Sequencing and Chromosomal Microarray tests. We also offer an affordable DNA banking service.
About ISO 15189:2012
ISO 15189:2012 incorporates the essential elements of ISO 9001 and adds technical competency factors relevant to clinical laboratories. ISO 15189:2015 certificaion includes both an assessment of the QMS and an evaluation of the technical competency of the laboratory, including Scope; Normative references; Terms and conditions; Management requirements; and Technical requirements.www.iso.org
PreventionGenetics is one of a few US based clinical genetic testing laboratories which have acquired the international quality assurance standard, making the company a provider of choice for international companies seeking NextGen panels, single gene tests, and deletion/duplication testing via high density gene-centric aCGH.
Formed in 2004, by Dr. James Weber, contributor to the Human Genome Project, PreventionGenetics is one of the most comprehensive genetic testing companies in the world. A large global contender, PreventionGenetics currently accepts samples routinely from over 70 countries, with comprehensive coverage for nearly 2,000 genes, in addition to whole exome sequencing (PGXome).
“ISO 15189:2012 provides the basis for which many health care systems and practitioners from all over the world use to select their preferred labs,” said Dr. James Weber, CEO and Founder. “We have built the foundation of this company on quality standards, supported by our large specialized PhD group. Certification confirms our lab standards for quality run as deep as our personal commitment to patient care through diagnostic expertise.”
ISO 15189:2012 defines specific quality and competency requirements particular to clinical laboratories. Certification confirms conditions within the laboratory setting are reproducible, leading to accurate results. The standard promotes global adoption of clinical practices for protection of the health and safety of patients and healthcare providers. ISO 15189:2012 also assesses the efficient exchange of information and protection of data for improved quality of care.
About Prevention Genetics
PreventionGenetics, LLC is a CAP and CLIA-accredited and ISO 15189:2012 certified lab which offers clinical molecular diagnostic testing for near 2,000 clinically-relevant genes. We offer a rapidly growing set of NextGen panels, single gene tests, and deletion/duplication testing. PreventionGenetics also offers Whole Exome Sequencing and Chromosomal Microarray tests. We also offer an affordable DNA banking service.
About ISO 15189:2012
ISO 15189:2012 incorporates the essential elements of ISO 9001 and adds technical competency factors relevant to clinical laboratories. ISO 15189:2015 certificaion includes both an assessment of the QMS and an evaluation of the technical competency of the laboratory, including Scope; Normative references; Terms and conditions; Management requirements; and Technical requirements.www.iso.org
Contact
PreventionGenetics
Rachel Reed
715-387-0484 ext. 169
https://preventiongenetics.com
Rachel Reed
715-387-0484 ext. 169
https://preventiongenetics.com
Contact
Categories